Greenwich LifeSciences Director and CEO Patel Snehal Buys 4600 Shares at $8.37/Share

viernes, 28 de noviembre de 2025, 6:17 am ET1 min de lectura
GLSI--

Greenwich LifeSciences, Inc. (GLSI) has announced that Director, 10% Owner, CEO, and CFO Patel Snehal has acquired 4,600 shares at a price of $8.37 per share on November 25, 2025.

Greenwich LifeSciences Director and CEO Patel Snehal Buys 4600 Shares at $8.37/Share

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios